Jin Medical International (ZJYL) Payables (2022 - 2025)

Jin Medical International (ZJYL) has reported Payables for 4 consecutive years, with $22.1 million the latest figure, recorded in Q3 2025.

• Quarterly Payables rose 54.13% year-over-year to $22.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $22.1 million (up 54.13% YoY) and the FY2025 annual result came in at $22.1 million, up 54.13% from the prior year.
• Payables improved to $22.1 million in Q3 2025 per ZJYL's latest filing, from $18.8 million in the prior quarter.
• Over the last five years, Payables for ZJYL reached as high as $22.1 million in Q3 2025 and fell as low as $4.1 million in Q3 2022.
• A 4-year average of $12.2 million and a median of $12.8 million in 2024 frame the typical range for Payables.
• Annual changes were most pronounced in 2024 — Payables jumped 111.32% — and 2025, when it soared 46.42%.
• Year by year, Payables stood at $4.1 million in 2022, then surged by 82.42% to $7.5 million in 2023, then soared by 91.03% to $14.3 million in 2024, then surged by 54.13% to $22.1 million in 2025.
• According to Business Quant data, Payables over the past three periods registered $22.1 million, $18.8 million, and $14.3 million for Q3 2025, Q1 2025, and Q3 2024 respectively.